These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 221590)

  • 1. Production of migration inhibition factor by spleen cells of normal rats upon culture in vitro with tumor cells and cells expressing endogenous virus.
    Sharma JM; Herberman RB; Djeu JY; Nunn ME
    J Immunol; 1979 Jul; 123(1):222-31. PubMed ID: 221590
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the cellular immune response to Gross virus-induced lymphoma by the mixed lymphocyte-tumor interaction.
    Glaser M; Herberman RB; Kirchner H; Djeu JY
    Cancer Res; 1974 Sep; 34(9):2165-71. PubMed ID: 4276482
    [No Abstract]   [Full Text] [Related]  

  • 5. T cells from naive mice suppress the in vitro cytotoxic response against endogenous Gross virus-induced tumor cells.
    Tilkin AF; Gomard E; Begue B; Levy JP
    J Immunol; 1984 Jan; 132(1):520-6. PubMed ID: 6228582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen.
    Gerlier D; Bakouche O; Dore JF
    J Immunol; 1983 Jul; 131(1):485-90. PubMed ID: 6190925
    [No Abstract]   [Full Text] [Related]  

  • 7. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1973 Sep; 111(3):667-71. PubMed ID: 4542607
    [No Abstract]   [Full Text] [Related]  

  • 8. [Kinetics of production of macrophage migration inhibitory factors in mixed culture of lymphocytes and tumor cells].
    Kharkevich DD; Suslov AP
    Biull Eksp Biol Med; 1982 Feb; 93(2):53-5. PubMed ID: 6461371
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro generation of secondary cell-mediated cytotoxic response against a syngeneic Gross virus-induced lymphoma in rats.
    Glaser M; Bonnard GD; Herberman RB
    J Immunol; 1976 Feb; 116(2):430-6. PubMed ID: 1082456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell interactions in leukemia-associated immunosuppression: suppression of thymus-independent antibody responses by leukemia spleen cells (Moloney) in vitro is mediated by normal T cells.
    Caulfield MJ; Cerny J
    J Immunol; 1980 Jan; 124(1):255-60. PubMed ID: 6965291
    [No Abstract]   [Full Text] [Related]  

  • 11. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of cytotoxic lymphocytes in vitro: response of immune rat spleen cells to a syngeneic gross virus-induced lymphoma in mixed lymphocyte-tumor culture.
    Bernstein ID; Wright PW; Cohen E
    J Immunol; 1976 May; 116(5):1367-72. PubMed ID: 58029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKR murine leukemia viruses and long-term bone marrow cultures from AKR and SJL mice.
    Hays EF; Warren J; Hale L; Rodensky D
    Exp Hematol; 1980 Jan; 8(1):134-46. PubMed ID: 6250871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 15. [Participation of spleen cells in regulating the production of macrophage migration inhibitory factor in mice].
    Koval'chuk LV; Sotnikova NIu
    Biull Eksp Biol Med; 1981 Mar; 91(3):336-8. PubMed ID: 7018617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages.
    Landolfo S; Herberman RB; Holden HT
    J Immunol; 1977 Apr; 118(4):1244-8. PubMed ID: 191532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation.
    Green WR
    J Immunol; 1986 Jan; 136(1):308-12. PubMed ID: 2999246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia virus-induced immunosuppression. IX. Depression of delayed hypersensitivity and MIF production after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1973 Dec; 111(6):1810-9. PubMed ID: 4584404
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells.
    Ting CC; Rodrigues D
    J Immunol; 1980 Mar; 124(3):1039-44. PubMed ID: 6444645
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenotypic heterogeneity of Moloney leukemia virus-induced T cel lymphomas.
    Pepersack L; Lee JC; McEwan R; Ihle JN
    J Immunol; 1980 Jan; 124(1):279-85. PubMed ID: 6965293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.